Tek Grup participated in the 1st Best of ESMO Levant 2026 Congress held in Baghdad on February 12–13, 2026. Bringing together approximately 280 oncology physicians from across Iraq and the Levant region, the event served as an important scientific platform where the latest treatment approaches were shared.
Throughout the congress, Tek Grup had the opportunity to present its oncology portfolio through one-on-one meetings with physicians, hospital managements, and pharmacists. These meetings also led to valuable contacts for direct procurement and private sector collaborations.
As part of the event, a company symposium was held focusing on Gemcitabine, highlighting its role in treatment protocols. In addition, meetings with key opinion leaders (KOLs) during the congress marked an important step toward future collaborations.
The new connections established and meetings held during the event marked an important starting point for future collaborations and planned educational activities.
